Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: involvement of the HER/PI3K/Akt/mTOR and IAP pathways
about
Molecular Portrait of the Normal Human Breast Tissue and Its Influence on Breast CarcinogenesisSynaptopodin couples epithelial contractility to α-actinin-4-dependent junction maturationOrthotopic injection of breast cancer cells into the mammary fat pad of mice to study tumor growth.RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells.Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR.Vertical uniformity of cells and nuclei in epithelial monolayers.E-cadherin genetic variants predict survival outcome in breast cancer patients.Therapeutic targets associated to E-cadherin dysfunction in gastric cancer.Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer.Glial cell-derived neurotrophic factor attenuates neuropathic pain in a mouse model of chronic constriction injury: possible involvement of E-cadherin/p120ctn signaling.The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.Roles of RUNX in Hippo Pathway Signaling.Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface.
P2860
Q26744296-669B3693-3671-42F8-873A-B164E8D3B372Q27310572-D2FD8552-66B3-4279-9EA7-4A8F6C05AB35Q35162196-CE966B04-D33B-4194-AD96-88518EAED20CQ36413997-8349303B-992F-4943-84C2-7BA0BF120828Q36462450-F634EA20-BEFC-4BD3-9E43-A9FD22DCB7AAQ36500563-416B772F-A048-44D0-8DC5-BAFA7491EE4FQ37419336-B18DA455-555A-483B-AC76-5834751F08FFQ38129925-AD50DDD2-636E-4B48-8569-9C6C0B5E46E1Q38679713-1ED897DD-38F4-4DD9-AE63-474642CED5D9Q39018249-E56C9F28-7F22-446B-AA29-371E720FCFBCQ47618731-AD9C26C0-1C4E-43FD-A6CE-3B5EAA59F30EQ47944350-CAB90088-245F-4DDA-B343-C465464DF0CFQ55196550-3A5C7E04-405A-4622-A54A-0E5AFDF0189E
P2860
Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: involvement of the HER/PI3K/Akt/mTOR and IAP pathways
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Monoclonal antibody against th ...... PI3K/Akt/mTOR and IAP pathways
@ast
Monoclonal antibody against th ...... PI3K/Akt/mTOR and IAP pathways
@en
Monoclonal antibody against the ectodomain of E-cadherin
@nl
type
label
Monoclonal antibody against th ...... PI3K/Akt/mTOR and IAP pathways
@ast
Monoclonal antibody against th ...... PI3K/Akt/mTOR and IAP pathways
@en
Monoclonal antibody against the ectodomain of E-cadherin
@nl
prefLabel
Monoclonal antibody against th ...... PI3K/Akt/mTOR and IAP pathways
@ast
Monoclonal antibody against th ...... PI3K/Akt/mTOR and IAP pathways
@en
Monoclonal antibody against the ectodomain of E-cadherin
@nl
P2093
P2860
P1476
Monoclonal antibody against th ...... PI3K/Akt/mTOR and IAP pathways
@en
P2093
Andrew Silberfeld
Carmen Tornos
M Kerry O'Banion
Sabine M Brouxhon
Stephanos Kyrkanides
Stephen Byers
Veena Raja
Xiaofei Teng
P2860
P304
P356
10.1158/1078-0432.CCR-12-2747
P407
P577
2013-04-25T00:00:00Z